Safeguard CEO featured on

Posted by | August 26, 2010

Last week, Safeguard Scientifics’ President and CEO Peter J. Boni sat down with Gregg Greenberg of to discuss the emergence of IPO candidates from the doldrums of last year’s lackluster activity.

Check out this video that highlights Peter’s insight as to why the tide might be turning in the IPO arena. In particular, Peter cites areas of increased activity: First, in later stage life science companies closer to revenue as opposed to those going through the earlier phases of the FDA-approval process; and second, in technology companies that bunkered down over the last two years during the economic downturn that are now re-emerging and looking for growth capital.

A podcast is also available (at 28:40 for those of you who don’t have time to listen to the whole piece) in which Peter and Gregg discuss IPOs as a “financing” event versus an “exit” event.

Peter also provides some insight on Tengion’s (Nasdaq: TNGN) and NuPathe’s (Nasdaq: PATH) recent IPOs, and Safeguard’s target segments within life sciences and technology.

(Visited 60 times, 1 visits today)

Tags: , , , , , , , , ,